Markets · Asia · ASX

RMD.AX ResMed

A$32.67 +0.46%

Asia · Health Care

Log

Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.

+0.46%

YTD

-23.10%

P/E

—

P/B

—

ROE

—

Div yield

—

Beta

-0.19

Market cap

—

RSI (14)

Next earnings

—

Previous session

close of Oct 9, 2026 · EOD, no live order book

Open

A$32.69

A$32.67

VWAP (n/a)

—

Day high

A$32.69

Day low

A$32.50

Volume

167K

VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.

Latest headlines

ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?

Yahoo Finance · Oct 5

2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off

Yahoo Finance · Oct 2

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

Yahoo Finance · Oct 1

This Stock Could Be the Big Winner Out of Oura’s IPO

Yahoo Finance · Sep 28

Is ResMed A Better Way Than Stryker To Own Medical Device Growth?

Yahoo Finance · Sep 28

ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand

Yahoo Finance · Sep 21

Headlines via Yahoo Finance · links open the source · not an endorsement.

Research & reports

TradingView ↗

Charts & analysis

Yahoo Finance ↗

Quote & news

External resources — availability and opinions are theirs, not ours.

This is reference data for your own analysis — not a recommendation to buy or sell RMD.AX. Try it in the Lab to size a position and see the risk.